Langer, Henning T.
Joshi, Aniket S.
Müller-Werdan, Ursula
Norman, Kristina
Article History
First Online: 14 April 2026
Competing interests
: H.T.L. has received honoraria as a consultant or speaker from Almac Discovery, Actimed Therapeutics, Novartis and Alchemab Therapeutics. The other authors declare no competing interests.